Evidence map›Paper›PMID 39262845›Full record

ArticleBioactive materials2024

Vancomycin-encapsulated hydrogel loaded microarc-oxidized 3D-printed porous Ti6Al4V implant for infected bone defects: Reconstruction, anti-infection, and osseointegration.

Teng Zhang, Wenhao Zhou, Wanliang Yang, Jingwei Bi, Hao Li, Xianlei Gao, Baoliang Zhang, Guidong Shi, Ka Li, Zhijian Wei and 2 more

Abstract read
In one paragraph

Article in Bioactive materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Teng ZhangDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Wenhao ZhouShaanxi Key Laboratory of Biomedical Metallic Materials, Northwest Institute for Non-ferrous Metal Research, Xi'an, 710016, China.
Wanliang YangDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Jingwei BiDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Hao LiDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Xianlei GaoDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Baoliang ZhangDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Guidong ShiDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Ka LiDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Zhijian WeiDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Xin PanDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.
Shiqing FengDepartment of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infected bone defect is a formidable clinical challenge. Conventional approaches to prevention and treatment for infected bone defects are unsatisfactory. The key elements of the treatment are bone defect reconstruction, anti-infection, and osteogenesis. Conventional treatment methods remain unsatisfactory owing to the absence of composite integrating materials with anti-infective, and osteogenic activities as well as proper mechanical strength at the same time. In this study, we fabricated a vancomycin-encapsulated hydrogel with bacteria-responsive release properties combined with a shaved porous (submicron-micron) three-dimensional-printed Ti6Al4V implant. The implant surface, modified with submicron-sized pores through microarc oxidation (MAO), showed enhanced osteogenic activity and integrated well with the hydrogel drug release system, enabling sustained vancomycin release.

Indexed as

Anti-infectionInfected bone defectsOsseointegrationPorous Ti6Al4V implants

Identifiers

PMID39262845
PMCPMC11388676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.